查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1801129

胃內球囊市場規模、佔有率、趨勢及預測（按產品、填充材料、植入程序、應用、最終用戶和地區），2025 年至 2033 年

Intragastric Balloons Market Size, Share, Trends and Forecast by Product, Filling Material, Implanting Procedure, Application, End-User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球胃內球囊市場規模達7,019萬美元。展望未來， IMARC Group估計，到2033年，市場規模將達到1.6963億美元，2025-2033年期間的複合年成長率為9.79%。 2024年，北美市場佔據主導地位。高肥胖率、先進的醫療保健、FDA的早期批准以及對非手術減肥的需求不斷成長，是影響胃內球囊市場佔有率的一些因素。

由於全球肥胖率上升以及與超重相關的健康問題日益嚴重，胃內球囊市場正在蓬勃發展。這些球囊提供了一種非手術性的、暫時性的減肥解決方案，吸引了那些尋求侵入性手術替代方案的患者。透過數位健康宣傳活動和醫療保健提供者的建議，人們的意識不斷提高，進一步刺激了需求。可吞嚥、充氣或可調節球囊等技術改進，提高了患者的舒適度並擴大了適用範圍。此外，一些國家推出的支持性保險政策以及醫療旅遊業的蓬勃發展，尤其是在提供價格合理的內視鏡手術的地區，也推動了胃內球囊的應用。新興市場的法規核准正在擴大胃內球囊的可及性，支持球囊對短期減肥有效的臨床證據也增強了其可信度。這些因素共同為胃內球囊市場的成長創造了有利環境，尤其是在生活方式相關健康問題日益嚴重的城市地區。

在美國，胃內球囊系統的新型設計正在推動非手術減肥方法的發展。一種可吞服的膠囊，具有定時放氣和自然排泄的功能，帶來了更高的便利性和安全性。隨著智慧財產權保護延伸至下一個十年，此類創新正在為更廣泛的應用和臨床認可奠定基礎。例如，2025年4月，ReShape Lifesciences公司收到了美國專利商標局（USPTO）對其胃內球囊專利（申請號18/241,151）的授權通知。該專利涵蓋一種帶有自密封填充閥和可分解釋放閥的可吞服膠囊，旨在三個月後放氣並自然排泄。該系統為非手術減肥解決方案增添了創新。該專利一旦獲得授權，其保護期至少持續到2031年1月。

胃內球囊市場趨勢：

非手術減重方法的需求日益成長

由於普遍存在的體重相關健康問題正在推動人們對非侵入性治療的興趣，胃內水球市場前景仍然樂觀。對於那些尋求在醫學監督下進行非手術減肥的人來說，胃內水球正成為一種首選。這些設備提供了一種可逆且低強度的治療方法，這對那些希望避免長期恢復期或永久性解剖變化的患者和臨床醫生都很有吸引力。其吸引力還在於能夠在醫生指導下將這些手術與生活方式的改變結合起來。隨著醫療保健系統在管理肥胖相關疾病方面面臨越來越大的壓力，人們更加重視安全、有效且經濟的早期介入方法。醫療界的宣傳活動和更廣泛的認可正在進一步推動胃內水球的應用，尤其是在那些無法獲得先進外科治療的地區。世界衛生組織 (WHO) 報告稱，2022 年，全球 18 歲及以上成年人超重 25 億，其中 8.9 億人患有肥胖症。

體重管理向微創手術轉變

臨床偏好正逐漸從傳統的開放性手術轉向微創手術。切口更小、住院時間更短、恢復更快的手術越來越受到醫生和病人的青睞。根據胃內球囊的市場預測，這種轉變反映了體重相關干預措施的廣泛變化，更注重安全性、便利性和減少術後併發症。胃內球囊恰好契合了這一趨勢，它提供了一種臨時的非手術治療方案，滿足了患者對低風險解決方案的需求。隨著越來越多的醫護人員採用微創方法，這類設備在注重病患舒適度和門診照護模式的臨床環境中得到了更廣泛的應用。韓國最近的一項調查顯示，開放性手術正逐漸轉向微創技術。開放性手術的採用率從2014年的49.8%下降到2019年的27.6%。

加強非手術減重設備的驗證

臨床研究正在增強人們對非手術減重計畫的信心。胃內水球因其能夠與生活方式介入相結合，帶來顯著效果而備受關注。最近的試驗資料突顯了其持續的減重效果和良好的安全性，支持其在尋求手術替代方案的患者中得到更廣泛的應用。這些發現正在影響醫生的決策，並可能塑造更廣泛應用的監管途徑。人們對那些能夠以最小風險提供可衡量結果的治療方法的興趣持續成長，尤其是在與結構化的生活方式支持相結合的情況下。在臨床實踐和患者偏好方面，微創方法的轉變正變得越來越明顯。這反映了胃內水球市場更廣泛的趨勢，即注重安全性、便利性和長期有效性。例如，2025年1月，Allurion Technologies公佈了其在FDA進行的Allurion水球關鍵性AUDACITY試驗的最終結果。超過550名參與者參與了試驗，接受了兩個水球週期或生活方式介入。在48週的治療中，58%的接受水球治療的患者體重減輕了5%以上。雖然與對照組相比，體重減輕差異（3.77%）在統計上未達到3%的優效性範圍，但在40週時已超過此範圍。嚴重不良事件發生率較低，為3.1%。

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球胃內球囊市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品

  • 單胃內球囊
  • 雙胃內球囊
  • 三重胃內球囊

第7章：市場區隔：按填充材料

  • 鹽水填充
  • 氣體填充

第8章：市場區隔：透過植入程序

  • 外科
  • 非手術

第9章：市場區隔：依應用

  • 肥胖
  • 糖尿病
  • 飲食控制
  • 減肥
  • 術前減重
  • 其他

第10章：市場區隔：依最終用戶

  • 醫院和診所
  • 門診手術中心
  • 其他

第 11 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第 12 章：SWOT 分析

第 13 章：價值鏈分析

第 14 章：波特五力分析

第 15 章：價格指標

第 16 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Apollo Endosurgery
    • Obalon Therapeutics Inc.
    • ReShape Medical Inc.
    • Medicone
    • Medsil
    • Allurion Technologies Inc.
    • Helioscopie
    • Spatz Fgia Inc.
    • PlenSat
    • Districlass Medical SA
    • Endalis
    • Lexel SRL
    • Silimed Inc.
    • Shandong Institute of Medical Instruments
Product Code: SR112025A2085

The global intragastric balloons market size was valued at USD 70.19 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 169.63 Million by 2033, exhibiting a CAGR of 9.79% during 2025-2033. North America dominated the market in 2024. High obesity rates, advanced healthcare, early FDA approvals, and growing demand for non-surgical weight loss are some of the factors contributing to the intragastric balloons market share.

The market is gaining traction due to increasing global obesity rates and rising health concerns linked to excess weight. These balloons offer a non-surgical, temporary weight loss solution, appealing to patients seeking alternatives to invasive procedures. Growing awareness through digital health campaigns and recommendations by healthcare providers has further boosted demand. Technological improvements, such as swallowable, gas-filled, or adjustable balloons, enhance patient comfort and broaden eligibility. Additionally, supportive insurance policies in some countries and the growth of medical tourism, particularly in regions offering affordable endoscopic procedures, are driving adoption. Regulatory approvals across new markets are expanding accessibility, and clinical evidence supporting balloon effectiveness for short-term weight loss adds to their credibility. Combined, these factors create a favorable environment for intragastric balloons market growth, especially in urban areas with rising lifestyle-related health issues.

In the United States, new designs in intragastric balloon systems are advancing non-surgical weight loss methods. A swallowable capsule with timed deflation and natural excretion introduces added convenience and safety. As intellectual property protections extend into the next decade, such innovations are setting the stage for broader use and clinical acceptance. For instance, in April 2025, ReShape Lifesciences received a Notice of Allowance from the USPTO for its intragastric balloon patent (application 18/241,151). The patent covers a swallowable capsule with a self-sealing fill valve and a degradable release valve, designed to deflate after three months and be naturally excreted. This system adds innovation to non-surgical weight loss solutions. The patent, once issued, offers protection through at least January 2031.

Intragastric Balloons Market Trends:

Growing Demand for Non-Surgical Weight Loss Alternatives

The intragastric balloons market outlook remains positive as widespread weight-related health issues are pushing interest in non-invasive treatments. Intragastric balloons are becoming a preferred option for those seeking medically supervised weight loss without surgery. These devices offer a reversible and less intensive approach, which appeals to both patients and clinicians aiming to avoid long recovery periods or permanent anatomical changes. The appeal also lies in the ability to integrate these procedures with lifestyle changes under medical guidance. As healthcare systems face mounting pressure to manage obesity-related conditions, there's a stronger emphasis on early intervention methods that are safe, effective, and cost-conscious. Awareness campaigns and broader acceptance within medical communities are further reinforcing adoption, especially in regions with limited access to advanced surgical care. The World Health Organization (WHO) reported that in 2022, 2.5 Billion adults aged 18 and above were overweight, with 890 Million of them living with obesity.

Shift toward Minimally Invasive Procedures in Weight Management

Clinical preferences are steadily moving away from traditional open surgery in favor of less invasive methods. Procedures that require smaller incisions, shorter hospital stays, and quicker recovery times are gaining favor among both practitioners and patients. Based on the intragastric balloons market forecast, this shift reflects a broader change in how weight-related interventions are approached, favoring safety, convenience, and reduced post-operative complications. Intragastric balloons fit neatly into this movement, offering a temporary, non-surgical option that aligns with patient demand for low-risk solutions. As more medical professionals adopt minimally invasive approaches, devices like these are seeing wider use in clinical settings that prioritize patient comfort and outpatient care models. A recent survey in Korea showed a shift from open surgery to minimally invasive techniques. The rate of open surgery dropped from 49.8% in 2014 to 27.6% in 2019.

Increased Validation of Non-Surgical Weight Loss Devices

Clinical studies are reinforcing confidence in non-surgical weight loss options. Intragastric balloons are drawing attention for their ability to deliver meaningful results alongside lifestyle programs. Recent trial data highlights sustained weight reduction over time with a favorable safety profile, supporting wider use in patients seeking alternatives to surgery. These findings are influencing physician decisions and could shape regulatory pathways for broader adoption. Interest continues to grow in treatments that offer measurable outcomes with minimal risk, especially when combined with structured lifestyle support. The shift toward less invasive methods is becoming more pronounced in clinical practice and patient preference alike. This reflects broader intragastric balloons market trends focused on safety, convenience, and long-term effectiveness. For example, in January 2025, Allurion Technologies reported topline results from its FDA pivotal AUDACITY trial on the Allurion Balloon. Over 550 participants joined, receiving two balloon cycles or lifestyle therapy. At 48 weeks, 58% of balloon recipients lost over 5% of body weight. Though the weight loss difference vs. controls (3.77%) missed the 3% superiority margin statistically, the margin was exceeded at 40 weeks. Serious adverse events were low at 3.1%.

Intragastric Balloons Industry Segmentation:

Analysis by Product:

  • Single Intragastric Balloon
  • Double Intragastric Balloon
  • Triple Intragastric Balloon

Single intragastric balloon stood as the largest product in 2024. This type of balloon is gaining traction due to its simpler placement procedure, lower cost compared to dual or adjustable variants, and fewer associated complications. It's usually inserted endoscopically and removed after six months, offering a less invasive alternative to bariatric surgery for short-term weight loss. Patients and clinicians often prefer this option for its safety profile, faster recovery, and minimal maintenance. As obesity rates climb and demand grows for non-surgical weight loss methods, single-balloon systems are seeing wider adoption across clinics. Their convenience and growing clinical acceptance make them a leading contributor to market expansion.

Analysis by Filling Material:

  • Saline Filling
  • Gas Filling

Saline filling led the market in 2024. These balloons are filled with sterile saline solution after placement in the stomach, making them safer and more widely accepted. Saline allows easy visualization on imaging, which helps in monitoring and ensures prompt response to any deflation. They also come with a blue dye indicator; if leakage occurs, the dye colors the urine, acting as an early warning system. This safety feature, combined with affordability and a long track record of clinical use, makes saline-filled balloons more appealing than gas-filled options. Their predictable performance and broader physician preference are accelerating their adoption, especially in outpatient settings and emerging markets where cost and reliability are key factors.

Analysis by Implanting Procedure:

  • Surgical
  • Non-Surgical

Non-surgical led the market in 2024 as more patients seek weight loss solutions that avoid the risks, recovery time, and cost of surgery. Intragastric balloons offer a minimally invasive approach, typically placed and removed via endoscopy or swallowed in capsule form, making them accessible to a wider population, including those who are not candidates for bariatric surgery. This appeals to individuals looking for a temporary, reversible option with fewer complications. Clinics and providers are also expanding their offerings to include non-surgical procedures to meet rising demand. The growing interest in outpatient and office-based treatments further supports this trend. Convenience, safety, and faster return to daily activities are making the non-surgical segment a key growth driver in this market.

Analysis by Application:

  • Obesity
  • Diabetes
  • Diet Control
  • Weight-Loss
  • Pre-Operative Weight Reduction
  • Others

Obesity led the market in 2024. With global obesity rates climbing steadily, more individuals are seeking effective weight management options beyond diet and exercise. Intragastric balloons offer a non-permanent, non-surgical intervention that supports initial weight loss and motivates lifestyle change. They are especially useful for patients with moderate obesity who may not qualify for bariatric surgery but still need medical intervention. As obesity is linked to conditions like diabetes, hypertension, and heart disease, healthcare providers are recommending earlier weight management strategies, including balloons. Rising awareness, insurance coverage improvements, and government health initiatives targeting obesity are also contributing to increased adoption, making the obesity segment a strong driver of market growth.

Analysis by End-User:

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others

Hospitals and clinics led the market in 2024, owing to their access to trained gastroenterologists, advanced endoscopic equipment, and post-procedure care. These settings are preferred for balloon placement and removal because they offer higher safety standards, patient monitoring, and comprehensive weight management programs. As awareness grows, more patients are turning to hospitals and specialty clinics for non-surgical obesity treatments. The rise in outpatient services and day-care procedures has made balloon insertion more convenient and cost-effective in these environments. Additionally, hospitals often partner with wellness programs and dieticians, offering patients a full treatment path. Their credibility, infrastructure, and capacity to handle complications make hospitals and clinics the go-to centers, boosting the segment's impact on market expansion.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2024, North America accounted for the largest market share. The region has one of the highest obesity rates globally, creating strong demand for effective, non-surgical weight-loss solutions. The presence of advanced healthcare infrastructure and well-established medical facilities enables widespread adoption of intragastric balloon procedures. Additionally, North America benefits from early regulatory approvals by agencies like the FDA, allowing quicker market access for innovative devices. High awareness levels among patients and healthcare professionals, along with strong marketing efforts by key manufacturers, also contribute to regional growth. Insurance coverage and reimbursement options in some areas further support patient access. Moreover, a growing preference for outpatient and minimally invasive procedures aligns well with balloon treatments. These combined factors continue to strengthen North America's leading position in the global intragastric balloons market.

Key Regional Takeaways:

United States Intragastric Balloons Market Analysis

The United States intragastric balloons market is primarily driven by the rising prevalence of obesity and related health complications. According to the new 2023 CDC population data, over one in three adults (35%) in 23 states are affected by obesity. Also, at least one in five adults (20%) in every U.S. state is currently living with obesity. In line with this, continual advances in balloon technology have significantly improved the safety and efficacy of procedures, attracting more patients to the market. The increasing awareness of non-surgical weight loss options is further driving market growth as individuals seek alternatives to traditional surgical procedures. Similarly, the growing preference for minimally invasive procedures, offering faster recovery times, is also fueling market demand. Furthermore, the heightened emphasis on preventive healthcare, motivating people to manage their weight actively, is fostering market expansion. Additionally, the rising trend of medical tourism is contributing to the market appeal as patients seek cost-effective solutions abroad. Moreover, favorable government initiatives and policies focused on obesity management are creating a supportive environment for market development, accelerating the adoption of intragastric balloon treatments.

Europe Intragastric Balloons Market Analysis

The market for intragastric balloons in Europe is experiencing growth due to the increasing prevalence of obesity and related chronic conditions. In accordance with this, the growing awareness of non-surgical weight loss options is encouraging patients to opt for minimally invasive treatments. Furthermore, ongoing advancements in intragastric balloon technology, which offers improved safety and effectiveness, are enhancing market appeal. The rise of medical tourism in Europe, where patients seek cost-effective solutions, is also contributing to market expansion. Additionally, supportive healthcare policies and reimbursement schemes across European countries are improving access to these treatments. The aging population in Europe, more prone to obesity, is another key market driver. The 2022 Health Survey for England found that individuals aged 55 to 74 were more likely to be overweight or obese compared to other age groups, with over 70% of people in these age ranges having excess weight. Additionally, preventive healthcare initiatives and a growing focus on wellness are fueling demand for weight management solutions. Apart from this, numerous collaborations between healthcare providers and research institutions are fostering innovation, further impacting market trends.

Asia Pacific Intragastric Balloons Market Analysis

The Asia Pacific market is predominantly driven by rapid urbanization and changing dietary habits, resulting in a larger patient base. In addition to this, growing awareness of minimally invasive procedures is prompting more individuals to opt for intragastric balloons as a non-surgical option. Furthermore, supportive government initiatives focusing on obesity management and preventive healthcare are fostering market growth. The region's increasing access to advanced medical technologies, which enhance the safety and effectiveness of treatments, is strengthening the market demand. Moreover, the expanding middle class, with higher disposable incomes, is fueling demand for weight loss treatments, providing further market potential. According to the People Research on India's Consumer Economy (PRICE), India's middle class is the fastest-growing segment, expanding at a rate of 6.3% annually, with an increase of 338 Million people from 1995 to 2021. It now constitutes 31% of the population and is projected to reach 38% by 2031 and 60% by 2047.

Latin America Intragastric Balloons Market Analysis

In Latin America, the market for intragastric balloons is expanding, predominantly driven by rising disposable income, which enables more individuals to afford weight loss treatments. Similarly, increasing awareness of minimally invasive procedures is encouraging individuals to opt for non-surgical options. The growing availability of advanced medical technologies, enhancing the safety and efficacy of treatments, is further fueling market expansion. Moreover, favorable government initiatives focused on addressing obesity through public health campaigns and improving healthcare access are making these treatments more accessible, strengthening the market's presence. As such, Novo Nordisk planned to invest USD 1.09 Billion in Brazil to expand production of Ozempic, Wegovy, and other injectable drugs. The investment will enhance manufacturing capacity at its Minas Gerais facility, with operations set to begin in 2028.

Middle East and Africa Intragastric Balloons Market Analysis

The market in the Middle East and Africa is significantly influenced by the growing awareness of obesity-related health risks and the need for effective weight loss solutions. The 2023 update from the World Obesity Federation's Global Observatory revealed that the UAE has a childhood obesity prevalence rate of 15% among girls (ranked 24th globally) and 18.5% among boys (ranked 21st globally). Furthermore, increasing access to modern medical treatments in the region, bolstered by investments in healthcare infrastructure, is accelerating market demand. Additionally, the region's growing health-conscious population, particularly among younger generations, is driving the need for minimally invasive weight loss options, thereby impelling the market. Moreover, various collaborative partnerships between local healthcare providers and global medical device companies are enhancing the availability and affordability of these treatments, providing an impetus to the market.

Competitive Landscape:

The intragastric balloon market is seeing steady activity with ongoing product launches, regulatory approvals, and research-driven innovation. Companies are introducing adjustable and non-invasive balloon systems to improve safety and patient comfort. Partnerships, mergers, and funding rounds are being used to expand product portfolios and global reach. Research institutions are contributing to the development of next-generation capsules with automated inflation features. While government initiatives mainly support obesity awareness and prevention, they indirectly benefit market growth. Among these, research and development, along with commercial partnerships, remain the most common practices, helping companies differentiate their offerings and meet regulatory requirements in new markets.

The report provides a comprehensive analysis of the competitive landscape in the intragastric balloons market with detailed profiles of all major companies, including:

  • Apollo Endosurgery
  • Obalon Therapeutics Inc.
  • ReShape Medical Inc.
  • Medicone
  • Medsil
  • Allurion Technologies Inc.
  • Helioscopie
  • Spatz Fgia Inc.
  • PlenSat
  • Districlass Medical SA
  • Endalis
  • Lexel SRL
  • Silimed Inc.
  • Shandong Institute of Medical Instruments

Key Questions Answered in This Report

  • 1.How big is the intragastric balloons market?
  • 2.What is the future outlook of intragastric balloons market?
  • 3.What are the key factors driving the intragastric balloons market?
  • 4.Which region accounts for the largest intragastric balloons market share?
  • 5.Which are the leading companies in the global intragastric balloons market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Intragastric Balloons Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Single Intragastric Balloon
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Double Intragastric Balloon
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Triple Intragastric Balloon
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Filling Material

  • 7.1 Saline Filling
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Gas Filling
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Implanting Procedure

  • 8.1 Surgical
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Non-Surgical
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Obesity
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Diabetes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Diet Control
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Weight-Loss
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Pre-Operative Weight Reduction
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast
  • 9.6 Others
    • 9.6.1 Market Trends
    • 9.6.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Hospitals and Clinics
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Ambulatory Surgical Centers
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Indicators

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Apollo Endosurgery
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Obalon Therapeutics Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
    • 16.3.3 ReShape Medical Inc.
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 Medicone
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Medsil
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 Allurion Technologies Inc.
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Helioscopie
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 Spatz Fgia Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 PlenSat
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
    • 16.3.10 Districlass Medical SA
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
    • 16.3.11 Endalis
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
    • 16.3.12 Lexel SRL
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
    • 16.3.13 Silimed Inc.
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio
    • 16.3.14 Shandong Institute of Medical Instruments
      • 16.3.14.1 Company Overview
      • 16.3.14.2 Product Portfolio

List of Figures

  • Figure 1: Global: Intragastric Balloons Market: Major Drivers and Challenges
  • Figure 2: Global: Intragastric Balloons Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Intragastric Balloons Market: Breakup by Product (in %), 2024
  • Figure 4: Global: Intragastric Balloons Market: Breakup by Filling Material (in %), 2024
  • Figure 5: Global: Intragastric Balloons Market: Breakup by Implanting Procedure (in %), 2024
  • Figure 6: Global: Intragastric Balloons Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Intragastric Balloons Market: Breakup by End-User (in %), 2024
  • Figure 8: Global: Intragastric Balloons Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Intragastric Balloons (Single Intragastric Balloon) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Intragastric Balloons (Single Intragastric Balloon) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Intragastric Balloons (Double Intragastric Balloon) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Intragastric Balloons (Double Intragastric Balloon) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Intragastric Balloons (Triple Intragastric Balloon) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Intragastric Balloons (Triple Intragastric Balloon) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Intragastric Balloons (Saline Filling) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Intragastric Balloons (Saline Filling) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Intragastric Balloons (Gas Filling) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Intragastric Balloons (Gas Filling) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Intragastric Balloons (Surgical Implant) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Intragastric Balloons (Surgical Implant) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Intragastric Balloons (Non-Surgical Implant) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Intragastric Balloons (Non-Surgical Implant) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Intragastric Balloons (Obesity) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Intragastric Balloons (Obesity) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Intragastric Balloons (Diabetes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Intragastric Balloons (Diabetes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Intragastric Balloons (Diet Control) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Intragastric Balloons (Diet Control) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Intragastric Balloons (Weight-Loss) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Intragastric Balloons (Weight-Loss) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Intragastric Balloons (Pre-Operative Weight Reduction) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Intragastric Balloons (Pre-Operative Weight Reduction) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Intragastric Balloons (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Intragastric Balloons (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Intragastric Balloons (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Intragastric Balloons (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Global: Intragastric Balloons (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Global: Intragastric Balloons (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Global: Intragastric Balloons (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Global: Intragastric Balloons (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: North America: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: North America: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: United States: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: United States: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Canada: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Canada: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Asia Pacific: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Asia Pacific: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: China: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: China: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Japan: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Japan: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: India: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: India: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: South Korea: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: South Korea: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Australia: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Australia: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Indonesia: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Indonesia: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Others: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Others: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Europe: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Europe: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Germany: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Germany: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: France: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: France: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: United Kingdom: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: United Kingdom: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Italy: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Italy: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Spain: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Spain: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Russia: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Russia: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Others: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Others: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Latin America: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Latin America: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Brazil: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Brazil: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Mexico: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Mexico: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Others: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 87: Others: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 88: Middle East and Africa: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 89: Middle East and Africa: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 90: Global: Intragastric Balloons Industry: SWOT Analysis
  • Figure 91: Global: Intragastric Balloons Industry: Value Chain Analysis
  • Figure 92: Global: Intragastric Balloons Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Intragastric Balloons Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Intragastric Balloons Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Intragastric Balloons Market Forecast: Breakup by Filling Material (in Million USD), 2025-2033
  • Table 4: Global: Intragastric Balloons Market Forecast: Breakup by Implanting Procedure (in Million USD), 2025-2033
  • Table 5: Global: Intragastric Balloons Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 6: Global: Intragastric Balloons Market Forecast: Breakup by End-User (in Million USD), 2025-2033
  • Table 7: Global: Intragastric Balloons Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 8: Global: Intragastric Balloons Market: Competitive Structure
  • Table 9: Global: Intragastric Balloons Market: Key Players